Logo
Sign in
Product Logo
Payer IntelligenceChryselys

AI‑driven SaaS platform unifying real‑world healthcare data to deliver real‑time, patient‑centric analytics for pharma teams.

chryselys_logo.jpg
Product details

Overview

Chryselys Patient Analytics Platform is a cloud‑native SaaS analytics solution built for the pharmaceutical and life sciences sector. It unifies disparate real‑world data such as claims, EMRs, lab results, and formulary information into a single dynamic environment. The platform goes beyond static dashboards, enabling real‑time cohort analysis, interactive queries via conversational AI, and actionable insights to support commercial, medical, and RWE decision‑making. Designed to reflect complex patient journeys, it helps identify adherence issues, access barriers, and treatment patterns that drive strategic planning and execution.

Features and Capabilities

  • Core Platform Capabilities:
    • Real‑world data integration from claims, EMRs, labs, and formularies.
    • Dynamic cohort building and segmentation in real time.
    • Real‑time insights for adherence, treatment drop‑offs, and access bottlenecks.
    • Conversational AI assistant for interactive, context‑aware queries.
  • Patient Journey Analytics:
    • Capture and map complete patient healthcare trajectories: symptom recognition, diagnosis, treatment, aftercare.
    • Quantify market potential and patient population sizing.
    • Segment patients for tailored care insights and improved experience outcomes.
    • Longitudinal analysis of compliance, persistency, and care gaps.
  • Advanced Data Processing and ML:
    • Data stacking and consolidation for analytics‑ready datasets across sources.
    • CUPID (common patient identifier) to reduce fragmentation and improve claims coverage.
    • Forecasting models for launch planning, demand forecasting, and scenario planning.
    • AI/ML‑driven insights with error detection and correction in complex healthcare data.
  • Decision Support:
    • Targeted alerts for treatment switches and patient behavior changes.
    • Cross‑functional usability for commercial strategy, finance, supply chain, and medical affairs.
    • Application across global commercial teams, CI analysts, market access, and medical strategy roles.